Pharma News

GENEVA (Reuters) - The World Health Organization (WHO) is reviewing a report that suggested its advice on the novel coronavirus needs updating, after some scientists told the New York ...

BENGALURU (Reuters) - Mylan NV said on Monday it would launch a generic version of Gilead Sciences Inc’s COVID-19 antiviral remdesivir in India at 4,800 rupees ($64.

The UK government has announced the launch of “one of the world’s largest comprehensive research studies” into the long-term health impacts of coronavirus on hospitalised patients.

Sanofi and Regeneron have reported that a late-stage trial assessing the potential of arthritis drug Kevzara (sarilumab) has been stopped after it failed to hit targets.

The US Food and Drug Administration (FDA) has approved ViiV Healthcare's novel attachment inhibitor Rukobia (fostemsavir) expanding treatment options for HIV.

A new study reveals that the asthma drug salbutamol may offer potential as a treatment for Alzheimer’s disease.

Granules Pharmaceuticals, Inc.

Tesla, the electric car company founded and run by Elon Musk, is building mobile molecular printers to assist Germany’s CureVac in manufacturing its experimental COVID-19 vaccine.

WUHAN, June 30 (Xinhua) -- A novel rabies vaccine for humans shows promise in preclinical testing, according to a new study published in the journal EBioMedicine.

People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society.

Researchers at Stanford University are developing a new insulin formulation that begins to take effect almost immediately upon injection, potentially working four times as fast as current commercial f...

EMD Serono, the biopharmaceutical business of Merck KGaA, and Pfizer today announced that the US Food and Drug Administration (FDA) has expanded use of Bavencio (avelumab) to include m...